Recipharm has appointed Henrik Stenqvist as the company's new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the headquarters in Stockholm, Sweden and reports to CEO Thomas Eldered.

Henrik Stenqvist brings 24 years' finance and management experience to Recipharm. Prior to joining the Swedish pharma Contract Development and Manufacturing Organization (CDMO) he served as CFO of the Meda Group and held other leading finance positions in the pharmaceutical industry. He holds a degree in Finance and Business Administration from the University of Linkoeping, Sweden.